These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
16-1387013
|
|
(State or other jurisdiction
|
(I.R.S. Employer Identification No.)
|
|
of incorporation or organization)
|
|
|
|
|
|
ULTRALIFE CORPORATION
|
|
CONDENSED
CONSOLIDATED BALANCE SHEETS
|
|
(Dollars in Thousands, Except Per Share Amounts)
|
|
ASSETS
|
(Unaudited)
June 30,
|
December 31,
2012
|
||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 11,158 | $ | 9,656 | ||||
|
Restricted cash
|
414 | 422 | ||||||
|
Trade accounts receivable (less allowance for doubtful accounts
of $305 at June 30, 2013 and $322 at December 31, 2012)
|
12,401 | 20,913 | ||||||
|
Inventories
|
31,021 | 30,370 | ||||||
|
Due from insurance company
|
438 | 723 | ||||||
|
Deferred tax asset - current
|
157 | 120 | ||||||
|
Income taxes receivable
|
120 | 28 | ||||||
|
Prepaid expenses and other current assets
|
1,468 | 1,590 | ||||||
|
Total current assets
|
57,177 | 63,822 | ||||||
|
Property, plant and equipment, net
|
11,249 | 12,415 | ||||||
|
Other assets:
|
||||||||
|
Goodwill
|
16,391 | 16,344 | ||||||
|
Intangible assets, net
|
4,844 | 5,039 | ||||||
|
Security deposits and other long-term assets
|
1,474 | 98 | ||||||
| 22,709 | 21,481 | |||||||
|
Total Assets
|
$ | 91,135 | $ | 97,718 | ||||
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Current portion of debt
|
$ | - | $ | - | ||||
|
Accounts payable
|
9,400 | 11,357 | ||||||
|
Income taxes payable
|
2 | 2 | ||||||
|
Deferred tax liability - current
|
74 | - | ||||||
|
Other current liabilities
|
4,900 | 8,533 | ||||||
|
Total current liabilities
|
14,376 | 19,892 | ||||||
|
Long-term liabilities:
|
||||||||
|
Deferred tax liability - long-term
|
4,298 | 4,160 | ||||||
|
Other long-term liabilities
|
195 | 210 | ||||||
|
Total long-term liabilities
|
4,493 | 4,370 | ||||||
|
Commitments and contingencies (Note 10)
|
||||||||
|
Shareholders' equity:
|
||||||||
|
Ultralife equity:
|
||||||||
|
Preferred stock, par value $0.10 per share, authorized 1,000,000 shares;
none issued and outstanding
|
- | - | ||||||
|
Common stock, par value $0.10 per share, authorized 40,000,000 shares;
issued - 18,831,734 at June 30, 2013 and 18,828,734 at December 31, 2012
|
1,886 | 1,886 | ||||||
|
Capital in excess of par value
|
174,233 | 173,791 | ||||||
|
Accumulated other comprehensive loss
|
(599 | ) | (620 | ) | ||||
|
Accumulated deficit
|
(95,522 | ) | (93,878 | ) | ||||
|
|
79,998 | 81,179 | ||||||
|
Less --Treasury stock, at cost -- 1,372,757 shares at June 30, 2013 and
1,372,757 shares at December 31, 2012
|
7,658 | 7,658 | ||||||
|
Total Ultralife equity
|
72,340 | 73,521 | ||||||
|
Noncontrolling interest
|
(74 | ) | (65 | ) | ||||
|
Total shareholders' equity
|
72,266 | 73,456 | ||||||
|
Total Liabilities and Shareholders' Equity
|
$ | 91,135 | $ | 97,718 | ||||
|
ULTRALIFE CORPORATION
|
|
CONDENSED
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
|
|
(In Thousands, Except Per Share Amounts)
|
|
(unaudited)
|
|
Three-Month Periods Ended
|
Six-Month Periods Ended
|
|||||||||||||||
|
June 30,
2013
|
July 1,
2012
|
June 30,
2013
|
July 1,
2012
|
|||||||||||||
|
Revenues
|
$ | 17,279 | $ | 18,706 | $ | 38,298 | $ | 46,207 | ||||||||
|
Cost of products sold
|
12,757 | 14,239 | 27,397 | 35,147 | ||||||||||||
|
Gross profit
|
4,522 | 4,467 | 10,901 | 11,060 | ||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Research and development (including $55, $65, $111 and $130,
respectively, of amortization of intangible assets)
|
1,669 | 1,970 | 3,038 | 4,109 | ||||||||||||
|
Selling, general, and administrative (including $43, $60, $88 and $120,
respectively, of amortization of intangible assets)
|
4,727 | 5,429 | 9,362 | 11,172 | ||||||||||||
|
Total operating expenses
|
6,396 | 7,399 | 12,400 | 15,281 | ||||||||||||
|
|
||||||||||||||||
|
Operating loss
|
(1,874 | ) | (2,932 | ) | (1,499 | ) | (4,221 | ) | ||||||||
|
Other income (expense):
|
||||||||||||||||
|
Interest income
|
12 | 2 | 14 | 3 | ||||||||||||
|
Interest expense
|
(43 | ) | (115 | ) | (133 | ) | (219 | ) | ||||||||
|
Miscellaneous
|
2 | (20 | ) | (23 | ) | 32 | ||||||||||
|
Loss from continuing operations before income taxes
|
(1,903 | ) | (3,065 | ) | (1,641 | ) | (4,405 | ) | ||||||||
|
|
||||||||||||||||
|
Income tax provision-current
|
23 | 188 | 61 | 267 | ||||||||||||
|
Income tax provision (benefit)-deferred
|
30 | (17 | ) | 90 | (5 | ) | ||||||||||
|
Total income taxes provision
|
53 | 171 | 151 | 262 | ||||||||||||
|
Net loss from continuing operations
|
(1,956 | ) | (3,236 | ) | (1,792 | ) | (4,667 | ) | ||||||||
|
Discontinued operations:
|
||||||||||||||||
|
Income (loss) from discontinued operations, net of tax
|
(120 | ) | 49 | 144 | (22 | ) | ||||||||||
|
Net loss
|
(2,076 | ) | (3,187 | ) | (1,648 | ) | (4,689 | ) | ||||||||
|
Net loss attributable to noncontrolling interest
|
3 | 20 | 9 | 20 | ||||||||||||
|
Net loss attributable to Ultralife
|
$ | (2,073 | ) | $ | (3,167 | ) | $ | (1,639 | ) | $ | (4,669 | ) | ||||
|
Other comprehensive income (loss):
|
||||||||||||||||
|
Foreign currency translation adjustments
|
148 | (25 | ) | 21 | 123 | |||||||||||
|
Comprehensive loss attributable to Ultralife
|
$ | (1,925 | ) | $ | (3,192 | ) | $ | (1,618 | ) | $ | (4,546 | ) | ||||
|
Net income (loss) attributable to Ultralife common shareholders - basic
|
||||||||||||||||
|
Continuing operations
|
$ | (0.11 | ) | $ | (0.18 | ) | $ | (0.10 | ) | $ | (0.27 | ) | ||||
|
Discontinued operations
|
$ | (0.01 | ) | $ | 0.00 | $ | 0.01 | $ | (0.00 | ) | ||||||
|
Total
|
$ | (0.12 | ) | $ | (0.18 | ) | $ | (0.09 | ) | $ | (0.27 | ) | ||||
|
Net income (loss) attributable to Ultralife common shareholders - diluted
|
||||||||||||||||
|
Continuing operations
|
$ | (0.11 | ) | $ | (0.18 | ) | $ | (0.10 | ) | $ | (0.27 | ) | ||||
|
Discontinued operations
|
$ | (0.01 | ) | $ | 0.00 | $ | 0.01 | $ | (0.00 | ) | ||||||
|
Total
|
$ | (0.12 | ) | $ | (0.18 | ) | $ | (0.09 | ) | $ | (0.27 | ) | ||||
|
Weighted average shares outstanding - basic
|
17,459 | 17,396 | 17,458 | 17,376 | ||||||||||||
|
Weighted average shares outstanding - diluted
|
17,459 | 17,396 | 17,458 | 17,376 | ||||||||||||
|
ULTRALIFE CORPORATION
|
|
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
(Dollars in Thousands)
|
|
(unaudited)
|
|
Six-Month Periods Ended
|
||||||||
|
June 30,
2013
|
July 1,
2012
|
|||||||
|
OPERATING ACTIVITIES
|
||||||||
|
Net loss
|
$ | (1,648 | ) | $ | (4,689 | ) | ||
|
Loss (income) from discontinued operations, net of tax
|
(144 | ) | 22 | |||||
|
Adjustments to reconcile net income (loss) from continuing operations
to net cash provided from operating activities:
|
||||||||
|
Depreciation and amortization of financing fees
|
1,637 | 1,717 | ||||||
|
Amortization of intangible assets
|
199 | 250 | ||||||
|
Loss on long-lived asset impairment
|
56 | - | ||||||
|
Loss on long-lived asset disposal and write-offs
|
- | 5 | ||||||
|
Foreign exchange loss (gain)
|
22 | (22 | ) | |||||
|
Non-cash stock-based compensation
|
430 | 670 | ||||||
|
Changes in deferred income taxes
|
172 | (5 | ) | |||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
8,543 | 5,190 | ||||||
|
Inventories
|
(592 | ) | 1,273 | |||||
|
Income taxes receivable
|
(91 | ) | 104 | |||||
|
Prepaid expenses and other assets
|
(1,456 | ) | (284 | ) | ||||
|
Due from Insurance Company
|
299 | 1,022 | ||||||
|
Income taxes payable
|
- | (9 | ) | |||||
|
Accounts payable and other liabilities
|
(4,384 | ) | (5,536 | ) | ||||
|
Net cash provided from (used in) operating activities from continuing operations
|
3,043 | (292 | ) | |||||
|
Net cash used in operating activities from discontinued operations
|
(998 | ) | - | |||||
|
Net cash provided from (used in) operating activities
|
2,045 | (292 | ) | |||||
|
INVESTING ACTIVITIES
|
||||||||
|
Purchase of property and equipment
|
(444 | ) | (1,546 | ) | ||||
|
Change in restricted cash
|
4 | - | ||||||
|
Net cash used in investing activities from continuing operations
|
(440 | ) | (1,546 | ) | ||||
|
Net cash provided from investing activities from discontinued operations
|
- | - | ||||||
|
Net cash used in investing activities
|
(440 | ) | (1,546 | ) | ||||
|
FINANCING ACTIVITIES
|
||||||||
|
Net change in revolving credit facility
|
- | 357 | ||||||
|
Proceeds from issuance of common stock
|
12 | 115 | ||||||
|
Net cash provided from financing activities from continuing operations
|
12 | 472 | ||||||
|
Net cash used in financing activities from discontinued operations
|
- | - | ||||||
|
Net cash provided from financing activities
|
12 | 472 | ||||||
|
Effect of exchange rate changes on cash
|
(115 | ) | 62 | |||||
|
Change in cash and cash equivalents
|
1,502 | (1,304 | ) | |||||
|
Cash and cash equivalents at beginning of period
|
9,656 | 5,320 | ||||||
|
Cash and cash equivalents at end of period
|
$ | 11,158 | $ | 4,016 | ||||
|
SUPPLEMENTAL CASH FLOW INFORMATION
|
||||||||
|
Cash paid for income taxes
|
$ | 74 | $ | 174 | ||||
|
Cash paid for interest
|
$ | 67 | $ | 146 | ||||
|
1.
|
BASIS OF PRESENTATION
|
|
2.
|
DISPOSITIONS AND EXIT ACTIVITIES
|
|
Three Month Periods Ended
|
Six Month Periods Ended
|
|||||||||||||||
|
June 30,
2013
|
July1,
2012
|
June 30,
2013
|
July1,
2012
|
|||||||||||||
|
Net sales
|
$ | - | $ | - | $ | - | $ | - | ||||||||
|
Gain from discontinued operations
|
- | - | 241 | - | ||||||||||||
|
Provision for income taxes
|
- | - | - | - | ||||||||||||
|
Gain from discontinued operations,
net of tax
|
- | - | 241 | - | ||||||||||||
|
Three Month Periods Ended
|
Six Month Periods Ended
|
|||||||||||||||
|
June 30,
2013
|
July 1,
2012
|
June 30,
2013
|
July 1,
2012
|
|||||||||||||
|
Net sales
|
$ | - | $ | 951 | $ | - | $ | 2,137 | ||||||||
|
Gain (loss) from discontinued operations
|
(118 | ) | 68 | (111 | ) | 56 | ||||||||||
|
Provision for income taxes
|
- | 12 | - | 23 | ||||||||||||
|
Gain (loss) from discontinued operations,
net of tax
|
(118 | ) | 56 | (111 | ) | 33 | ||||||||||
|
3.
|
INVENTORIES
|
|
June 30, 2013
|
December 31, 2012
|
|||||||
|
Raw materials
|
$ | 16,346 | $ | 15,023 | ||||
|
Work in process
|
3,470 | 4,863 | ||||||
|
Finished goods
|
11,205 | 10,484 | ||||||
| $ | 31,021 | $ | 30,370 | |||||
|
4.
|
PROPERTY, PLANT AND EQUIPMENT
|
|
June 30, 2013
|
December 31, 2012
|
|||||||
|
Land
|
$ | 123 | $ | 123 | ||||
|
Buildings and leasehold improvements
|
7,402 | 7,381 | ||||||
|
Machinery and equipment
|
46,552 | 46,606 | ||||||
|
Furniture and fixtures
|
1,928 | 1,810 | ||||||
|
Computer hardware and software
|
4,198 | 4,103 | ||||||
|
Construction in progress
|
1,138 | 1,275 | ||||||
| 61,341 | 61,298 | |||||||
|
Less: Accumulated depreciation
|
50,092 | 48,883 | ||||||
| $ | 11,249 | $ | 12,415 | |||||
|
5.
|
GOODWILL, INTANGIBLE ASSETS AND LONG TERM ASSETS
|
|
Battery &
Energy Products
|
Communications
Systems
|
Discontinued
Operations
|
Total
|
|||||||||||||
|
Balance at December 31, 2011
|
$ | 4,838 | $ | 11,493 | $ | 2,025 | $ | 18,356 | ||||||||
|
Effect of foreign currency
Translations
|
23 | - | - | 23 | ||||||||||||
|
Balance at July 1, 2012
|
4,861 | 11,493 | 2,025 | 18,379 | ||||||||||||
|
Sale of RedBlack
Communications
|
(2,025 | ) | (2,025 | ) | ||||||||||||
|
Effect of foreign currency
Translations
|
(10 | ) | - | - | (10 | ) | ||||||||||
|
Balance at December 31, 2012
|
4,851 | 11,493 | - | 16,344 | ||||||||||||
|
Effect of foreign currency
translations
|
47 | - | - | 47 | ||||||||||||
|
Balance at June 30, 2013
|
$ | 4,898 | $ | 11,493 | $ | - | $ | 16,391 | ||||||||
|
June 30, 2013
|
||||||||||||
|
Gross
Assets
|
Accumulated
Amortization
|
Net
|
||||||||||
|
Trademarks
|
$ | 3,566 | $ | - | $ | 3,566 | ||||||
|
Patents and technology
|
4,505 | 3,822 | 683 | |||||||||
|
Customer relationships
|
4,020 | 3,469 | 551 | |||||||||
|
Distributor relationships
|
388 | 344 | 44 | |||||||||
|
Non-compete agreements
|
218 | 218 | - | |||||||||
|
Total intangible assets
|
$ | 12,697 | $ | 7,853 | $ | 4,844 | ||||||
|
December 31, 2012
|
||||||||||||
|
Gross
Assets
|
Accumulated
Amortization
|
Net
|
||||||||||
|
Trademarks
|
$ | 3,564 | $ | - | $ | 3,564 | ||||||
|
Patents and technology
|
4,495 | 3,702 | 793 | |||||||||
|
Customer relationships
|
3,998 | 3,366 | 632 | |||||||||
|
Distributor relationships
|
380 | 330 | 50 | |||||||||
|
Non-compete agreements
|
217 | 217 | - | |||||||||
|
Total intangible assets
|
$ | 12,654 | $ | 7,615 | $ | 5,039 | ||||||
|
6.
|
DEBT
|
|
Quarterly Average Undrawn
Borrowing Availability
|
Applicable Margin for
Alternate Base Rate Loans
|
Applicable Margin for
LIBOR Rate Loans
|
|
Greater than $8,000,000
|
1.00%
|
2.00%
|
|
$5,000,000 up to $8,000,000
|
1.25%
|
2.25%
|
|
Less than $5,000,000
|
1.50%
|
2.50%
|
|
7.
|
SHAREHOLDERS’ EQUITY
|
|
Six Month Periods Ended
|
||||||||
|
June 30,
2013
|
July 1,
2012
|
|||||||
|
Risk-free interest rate
|
0.68 | % | 0.59 | % | ||||
|
Volatility factor
|
62.60 | % | 62.88 | % | ||||
|
Dividends
|
0.00 | % | 0.00 | % | ||||
|
Weighted average expected life (years)
|
4.06 | 3.91 | ||||||
|
Number
of Shares
|
Weighted
Average
Exercise Price
Per Share
|
Weighted
Average
Remaining
Contractual
Term (Years)
|
Aggregate
Intrinsic Value
|
||||||||||
|
Shares under option at January 1, 2013
|
2,211,488 | $ | 7.47 | ||||||||||
|
Options granted
|
153,000 | 3.49 | |||||||||||
|
Options exercised
|
(3,000 | ) | 3.91 | ||||||||||
|
Options forfeited
|
(29,882 | ) | 4.26 | ||||||||||
|
Options expired
|
(162,068 | ) | 10.87 | ||||||||||
|
Shares under option at June 30, 2013
|
2,169,538 | $ | 6.98 |
4.58
|
$ | 74 | |||||||
|
Vested and expected to vest as of
June 30, 2013
|
1,958,735 | $ | 7.22 |
4.53
|
$ | 56 | |||||||
|
Options exercisable at June 30, 2013
|
960,662 | $ | 6.72 |
3.59
|
$ | 0 | |||||||
|
Six Month Period Ended
|
||||
|
June 30,
2013
|
||||
|
Risk-free interest rate
|
0.21 | % | ||
|
Volatility factor
|
59.08 | % | ||
|
Dividends
|
0.00 | % | ||
|
Three Month
Period Ended
June 30, 2013
|
||||
|
Number of shares award
|
120,000 | |||
|
Weighted average fair value per share
|
$ | 3.62 | ||
|
Aggregate total value
|
$ | 434 | ||
|
Number of
Shares
|
Weighted
Average
Grant Date
Fair Value
|
|||||||
|
Unvested at January 1, 2013
|
0 | $ | 0 | |||||
|
Granted
|
120,000 | $ | 3.62 | |||||
|
Vested
|
0 | 0 | ||||||
|
Forfeited
|
0 | 0 | ||||||
|
Unvested at June 30, 2013
|
120,000 | $ | 3.62 | |||||
|
8.
|
INCOME TAXES
|
|
Three Month Periods Ended
|
Six Month Periods Ended
|
|||||||||||||||
|
June 30,
2013
|
July 1,
2012
|
June 30,
2013
|
July 1,
2012
|
|||||||||||||
|
Loss from continuing operations
before Incomes Taxes (a)
|
$ | (1,903 | ) | $ | (3,065 | ) | $ | (1,641 | ) | $ | (4,405 | ) | ||||
|
Total Income Tax Provision (b)
|
$ | 53 | $ | 171 | $ | 151 | $ | 262 | ||||||||
|
Effective Tax Rate (b/a)
|
2.8 | % | 5.6 | % | 9.2 | % | 5.9 | % | ||||||||
|
Six Month Periods Ended
|
||||||||
|
June 30,
2013
|
July 1,
2012
|
|||||||
|
Balance at beginning of the period
|
$ | 7,508 | $ | 6,779 | ||||
|
Increases related to current year tax
positions
|
- | - | ||||||
|
Increases related to prior year tax positions
|
- | - | ||||||
|
Decreases related to prior year tax positions
|
- | - | ||||||
|
Expiration of statute of limitations for
assessment of taxes
|
- | - | ||||||
|
Settlements
|
- | - | ||||||
|
Balance at end of the period
|
$ | 7,508 | $ | 6,779 | ||||
|
9.
|
EARNINGS PER SHARE
|
|
Three Month Period Ended
|
Six Month Period Ended
|
|||||||||||||||
|
June 30,
2013
|
July 1,
2012
|
June 30,
2013
|
July 1,
2012
|
|||||||||||||
|
Net Loss from continuing
operations attributable to Ultralife
|
$ | (1,953 | ) | $ | (3,216 | ) | $ | (1,783 | ) | $ | (4,647 | ) | ||||
|
Net Loss from continuing
operations attributable to participating securities (unvested restricted stock awards) (-0-, -0-, -0- and -0- shares, respectively)
|
- | - | - | - | ||||||||||||
|
Net Loss from continuing
operations attributable to Ultralife common shareholders (a)
|
(1,953 | ) | (3,216 | ) | (1,783 | ) | (4,647 | ) | ||||||||
|
Effect of Dilutive Securities
|
- | - | - | - | ||||||||||||
|
Net Loss from continuing
operations attributable to Ultralife common shareholders - Adjusted (b)
|
$ | (1,953 | ) | $ | (3,216 | ) | $ | (1,783 | ) | $ | (4,647 | ) | ||||
|
Net Income (Loss) from discontinued
operations attributable to Ultralife common shareholders (c)
|
$ | (120 | ) | $ | 49 | $ | 144 | $ | (22 | ) | ||||||
|
Effect of Dilutive Securities
|
- | - | - | - | ||||||||||||
|
Net Income (Loss) from discontinued
operations attributable to Ultralife common shareholders - Adjusted (d)
|
$ | (120 | ) | $ | 49 | $ | 144 | $ | (22 | ) | ||||||
|
Average Common Shares Outstanding –
Basic (e)
|
17,459,000 | 17,396,000 | 17,458,000 | 17,376,000 | ||||||||||||
|
Effect of Dilutive Securities:
Stock Options / Warrants
|
- | - | - | - | ||||||||||||
|
Average Common Shares Outstanding –
Diluted (f)
|
17,459,000 | 17,396,000 | 17,458,000 | 17,376,000 | ||||||||||||
|
EPS – Basic (a/e) - continuing operations
|
$ | (0.11 | ) | $ | (0.18 | ) | $ | (0.10 | ) | $ | (0.27 | ) | ||||
|
EPS – Basic (c/e) - discontinued operations
|
$ | (0.01 | ) | $ | 0.00 | $ | 0.01 | $ | (0.00 | ) | ||||||
|
EPS – Diluted (b/f) - continuing operations
|
$ | (0.11 | ) | $ | (0.18 | ) | $ | (0.10 | ) | $ | (0.27 | ) | ||||
|
EPS – Diluted (d/f) - discontinued operations
|
$ | (0.01 | ) | $ | 0.00 | $ | 0.01 | $ | (0.00 | ) | ||||||
|
10.
|
COMMITMENTS AND CONTINGENCIES
|
|
Balance at December 31, 2012
|
$ | 607 | ||
|
Accruals for warranties issued
|
120 | |||
|
Settlements made
|
(46 | ) | ||
|
Balance at June 30, 2013
|
$ | 681 |
|
11.
|
BUSINESS SEGMENT INFORMATION
|
|
Three Month Period Ended June 30, 2013
|
||||||||||||||||||||
|
Battery &
Energy
Products
|
Communications
Systems
|
Discontinued
Operations
|
Corporate
|
Total
|
||||||||||||||||
|
Revenues
|
$ | 14,656 | $ | 2,623 | $ | - | $ | - | $ | 17,279 | ||||||||||
|
Segment contribution
|
3,490 | 1,032 | - | (6,396 | ) | (1,874 | ) | |||||||||||||
|
Interest expense, net
|
(31 | ) | (31 | ) | ||||||||||||||||
|
Miscellaneous
|
2 | 2 | ||||||||||||||||||
|
Income taxes-current
|
(23 | ) | (23 | ) | ||||||||||||||||
|
Income taxes-deferred
|
(30 | ) | (30 | ) | ||||||||||||||||
|
Loss from discontinued operations
|
(120 | ) | (120 | ) | ||||||||||||||||
|
Noncontrolling interest
|
3 | 3 | ||||||||||||||||||
|
Net loss attributable to Ultralife
|
$ | (2,073 | ) | |||||||||||||||||
|
Total assets
|
$ | 44,357 | $ | 31,711 | $ | - | $ | 15,067 | $ | 91,135 | ||||||||||
|
Three Month Period Ended July 1, 2012
|
||||||||||||||||||||
|
Battery &
Energy
Products
|
Communications
Systems
|
Discontinued
Operations
|
Corporate
|
Total
|
||||||||||||||||
|
Revenues
|
$ | 15,523 | $ | 3,183 | $ | - | $ | - | $ | 18,706 | ||||||||||
|
Segment contribution
|
3,763 | 704 | - | (7,399 | ) | (2,932 | ) | |||||||||||||
|
Interest expense, net
|
(113 | ) | (113 | ) | ||||||||||||||||
|
Miscellaneous
|
(20 | ) | (20 | ) | ||||||||||||||||
|
Income taxes-current
|
(188 | ) | (188 | ) | ||||||||||||||||
|
Income taxes-deferred
|
17 | 17 | ||||||||||||||||||
|
Income from discontinued operations
|
49 | 49 | ||||||||||||||||||
|
Noncontrolling interest
|
20 | 20 | ||||||||||||||||||
|
Net loss attributable to Ultralife
|
$ | (3,167 | ) | |||||||||||||||||
|
Total assets
|
$ | 51,477 | $ | 30,548 | $ | 2,759 | $ | 8,207 | $ | 92,991 | ||||||||||
|
Six Month Period Ended June 30, 2013
|
||||||||||||||||||||
|
Battery &
Energy
Products
|
Communications
Systems
|
Discontinued
Operations
|
Corporate
|
Total
|
||||||||||||||||
|
Revenues
|
$ | 27,709 | $ | 10,589 | $ | - | $ | - | $ | 38,298 | ||||||||||
|
Segment contribution
|
6,590 | 4,311 | - | (12,400 | ) | (1,499 | ) | |||||||||||||
|
Interest expense, net
|
(119 | ) | (119 | ) | ||||||||||||||||
|
Miscellaneous
|
(23 | ) | (23 | ) | ||||||||||||||||
|
Income taxes-current
|
(61 | ) | (61 | ) | ||||||||||||||||
|
Income taxes-deferred
|
(90 | ) | (90 | ) | ||||||||||||||||
|
Gain from discontinued operations
|
144 | 144 | ||||||||||||||||||
|
Noncontrolling interest
|
9 | 9 | ||||||||||||||||||
|
Net loss attributable to Ultralife
|
$ | (1,639 | ) | |||||||||||||||||
|
Total assets
|
$ | 44,357 | $ | 31,711 | $ | - | $ | 15,067 | $ | 91,135 | ||||||||||
|
Six Month Period Ended July 1, 2012
|
||||||||||||||||||||
|
Battery &
Energy
Products
|
Communications
Systems
|
Discontinued
Operations
|
Corporate
|
Total
|
||||||||||||||||
|
Revenues
|
$ | 35,605 | $ | 10,602 | $ | - | $ | - | $ | 46,207 | ||||||||||
|
Segment contribution
|
7,706 | 3,354 | - | (15,281 | ) | (4,221 | ) | |||||||||||||
|
Interest expense, net
|
(216 | ) | (216 | ) | ||||||||||||||||
|
Miscellaneous
|
32 | 32 | ||||||||||||||||||
|
Income taxes-current
|
(267 | ) | (267 | ) | ||||||||||||||||
|
Income taxes-deferred
|
5 | 5 | ||||||||||||||||||
|
Loss from discontinued operations
|
(22 | ) | (22 | ) | ||||||||||||||||
|
Noncontrolling interest
|
20 | 20 | ||||||||||||||||||
|
Net loss attributable to Ultralife
|
$ | (4,669 | ) | |||||||||||||||||
|
Total assets
|
$ | 51,477 | $ | 30,548 | $ | 2,759 | $ | 8,207 | $ | 92,991 | ||||||||||
|
12.
|
FAIR VALUE OF FINANCIAL INSTRUMENTS
|
|
13.
|
FIRE AT MANUFACTURING FACILITY
|
|
14.
|
RECENT ACCOUNTING PRONOUNCEMENTS AND DEVELOPMENTS
|
|
Three Month Periods Ended
|
||||||||
|
June 30, 2013
|
July 1, 2012
|
|||||||
|
Loss before Incomes Taxes (a)
|
$ | (1,903 | ) | $ | (3,065 | ) | ||
|
Total Income Tax Provision (b)
|
$ | 53 | $ | 171 | ||||
|
Effective Tax Rate (b/a)
|
2.8 | % | 5.6 | % | ||||
|
Six Month Periods Ended
|
||||||||
|
June 30, 2013
|
July 1, 2012
|
|||||||
|
Loss before Incomes Taxes (a)
|
$ | (1,641 | ) | $ | (4,405 | ) | ||
|
Total Income Tax Provision (b)
|
$ | 151 | $ | 262 | ||||
|
Effective Tax Rate (b/a)
|
9.2 | % | 5.9 | % | ||||
|
·
|
Adjusted EBITDA from continuing operations does not reflect (1) our cash expenditures or future requirements for capital expenditures or contractual commitments; (2) changes in, or cash requirements for, our working capital needs; (3) the interest expense, or the cash requirements necessary to service interest or principal payments, on our debt; (4) income taxes or the cash requirements for any tax payments; and (5) all of the costs associated with operating our business;
|
|
·
|
although depreciation and amortization are non-cash charges, the assets being depreciated and amortized often will have to be replaced in the future, and Adjusted EBITDA from continuing operations does not reflect any cash requirements for such replacements;
|
|
·
|
while stock-based compensation is a component of cost of products sold and operating expenses, the impact on our consolidated financial statements compared to other companies can vary significantly due to such factors as assumed life of the stock-based awards and assumed volatility of our common stock;
|
|
·
|
although discontinued operations does not reflect our current business operations, discontinued operations includes the costs we incurred by exiting our Energy Services and certain of our UK businesses and divesting our RedBlack Communications business; and
|
|
·
|
other companies may calculate Adjusted EBITDA from continuing operations differently than we do, limiting its usefulness as a comparative measure.
|
|
Three Month Periods Ended
|
Six Month Periods Ended
|
|||||||||||||||
|
June 30,
2013
|
July 1,
2012
|
June 30,
2013
|
July 1,
2012
|
|||||||||||||
|
Net loss attributable to Ultralife
|
$ | (2,073 | ) | $ | (3,167 | ) | $ | (1,639 | ) | $ | (4,669 | ) | ||||
|
Add: interest expense, net
|
31 | 113 | 119 | 216 | ||||||||||||
|
Add: income tax provision
|
53 | 171 | 151 | 262 | ||||||||||||
|
Add: depreciation expense
|
729 | 824 | 1,559 | 1,660 | ||||||||||||
|
Add: amortization of intangible assets
|
98 | 125 | 199 | 250 | ||||||||||||
|
Add: stock-based compensation expense
|
240 | 329 | 430 | 670 | ||||||||||||
|
Add (Less): loss (gain) from
discontinued operations
|
120 | (49 | ) | (144 | ) | 22 | ||||||||||
|
Adjusted EBITDA
|
$ | (802 | ) | $ | (1,654 | ) | $ | 675 | $ | (1,589 | ) | |||||
|
Quarterly Average Undrawn
Borrowing Availability
|
Applicable Margin for
Alternate Base Rate Loans
|
Applicable Margin for
LIBOR Rate Loans
|
|
Greater than $8,000,000
|
1.00%
|
2.00%
|
|
$5,000,000 up to $8,000,000
|
1.25%
|
2.25%
|
|
Less than $5,000,000
|
1.50%
|
2.50%
|
|
Exhibit
Index
|
Description of Document
|
Incorporated By Reference from:
|
|
|
10.1
|
Revolving Credit, Guaranty, and Security Agreement between Ultralife Corporation and PNC Bank, National Association, dated as of May 24, 2013
|
Filed herewith
|
|
|
10.2
†
|
Retirement and Consulting Agreement, Release and Waiver of All Claims, between Ultralife Corporation and Peter F. Comerford, dated May 28, 2013
|
Filed herewith
|
|
|
10.3
†
|
Restricted Stock Unit Agreement between Ultralife Corporation and Michael D. Popielec. Dated June 4, 2013
|
Filed herewith
|
|
|
10.4
†
|
Amended and Restated 204 Long-Term Incentive Plan
|
Appendix B of Form DEF 14A filed on April 22, 2013
|
|
|
31.1
|
Rule 13a-14(a) / 15d-14(a) CEO Certifications
|
Filed herewith
|
|
|
31.2
|
Rule 13a-14(a) / 15d-14(a) CFO Certifications
|
Filed herewith
|
|
|
32
|
Section 1350 Certifications
|
Filed herewith
|
|
|
*101.INS
|
XBRL Instance Document
|
||
|
*101.SCH
|
XBRL Taxonomy Extension Schema Document
|
||
|
*101.CAL
|
XBRL Taxonomy Calculation Linkbase Document
|
||
|
*101.LAB
|
XBRL Taxonomy Label Linkbase Document
|
||
|
*101.PRE
|
XBRL Taxonomy Presentation Linkbase Document
|
||
|
*101.DEF
|
XBRL Taxonomy Definition Document
|
|
†
|
Management contract or compensatory plan or arrangement.
|
|
*
|
Pursuant to Rule 406T of Regulation S-T, the information in this exhibit is deemed not filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is otherwise not subject to liability under these sections.
|
|
|
10.1
|
Revolving Credit, Guaranty, and Security Agreement between Ultralife Corporation and PNC Bank, National Association, dated as of May 24, 2013
|
|
|
10.2
|
Retirement and Consulting Agreement, Release and Waiver of All Claims, between Ultralife Corporation and Peter F. Comerford, dated May 28, 2013
|
|
|
10.3
|
Restricted Stock Unit Agreement between Ultralife Corporation and Michael D. Popielec. Dated June 4, 2013
|
|
|
31.1
|
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
31.2
|
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
32
|
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
101.INS
|
XBRL Instance Document
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
|
101.CAL
|
XBRL Taxonomy Calculation Linkbase Document
|
|
|
101.LAB
|
XBRL Taxonomy Label Linkbase Document
|
|
|
101.PRE
|
XBRL Taxonomy Presentation Linkbase Document
|
|
|
101.DEF
|
XBRL Taxonomy Definition Document
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|